Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Merrimack Pharmaceuticals Inc. sell StockNews.com

Merrimack Pharmaceuticals Inc.
Start price
€3.98
24.06.23 / 50%
Target price
-
24.06.24
Performance (%)
-
End price
-
25.06.24
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y 3y
Merrimack Pharmaceuticals Inc. - - - -
iShares Core DAX® -1.586% 5.028% 6.332% 64.061%
iShares Nasdaq 100 -4.148% -0.125% 25.735% 86.918%
iShares Nikkei 225® -6.302% 0.528% 41.384% 77.872%
iShares S&P 500 -3.225% 0.470% 20.449% 68.192%

Comments by StockNews_com for this prediction

In the thread Merrimack Pharmaceuticals Inc. diskutieren

Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for MACK provided by MarketBeat

StockNews.com 
0
Report Share
24.06.23 Sell -
In the thread Trading Merrimack Pharmaceuticals Inc.
Prediction Sell
Perf. (%) -
Target price
Change
Ends at 24.06.24

Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

StockNews.com 
0
Report Share
25.06.24

Stopped prediction by StockNews_com for Merrimack Pharmaceuticals Inc.

sell
Merrimack Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.98
08.07.23
-
08.07.24
-
09.07.24

StockNews.com 
08.07.23 50%